Interestingly, treatment with M3 decreased CFTR expression in some non-CF donors and the combination of roscovitine plus tezacaftor/ivacaftor significantly increased CFTR expression in non-CF (Fig. 4B,C). Here, CFTR is linked to cystic fibrosis.